(Q33233009)

24 July 2017

0 references

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin (English)

1 reference

24 July 2017

main subject

Staphylococcus aureus

1 reference

Daniel J Skiest

1

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Journal of Clinical Microbiology

24 July 2017

published in

1 reference

24 July 2017

volume

44

1 reference

24 July 2017

issue

2

1 reference

24 July 2017

page(s)

655-656

1 reference

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

24 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1392696

The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1392696

Resistance studies with daptomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1392696

In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1392696

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1392696

10.1128/JCM.44.2.655-656.2006

31 October 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference

24 July 2017

1 reference